Associate Prof David Curtis |
Following medical training as a clinical haematologist and bone marrow transplant physician, David completed his PhD at the Walter and Eliza Hall Institute for Medical Research WEHI in 1998, where he utilised transgenic mouse models to study oncogene collaboration in leukemia.
After a three year post-doctoral stint at the National Institutes of Health, USA, David returned to establish an independent research program using mouse models to understand the genetic and epigenetic regulation of hematopoietic stem cells.
His translational research strategy is to develop and study mice that harbour common gene mutations found in human acute leukaemia, focusing on leukemic stem cells; rare cells within the leukaemia that are responsible for the development of leukaemia and resistance to our current treatments.
His translational research strategy is to develop and study mice that harbour common gene mutations found in human acute leukaemia, focusing on leukemic stem cells; rare cells within the leukaemia that are responsible for the development of leukaemia and resistance to our current treatments.
All welcome, see details:
- Time: 8.00 am registration for 9.00 am start. Drinks and canapes from 6-8 pm
- Venue: AMREP Lecture Theatre, adjacent to the BakerIDI Institute at 85 Commercial Road, Melbourne 3004, 200 metres east of the main Alfred Hospital entrance. See map.
- Cost: Free
- RSVP by Friday 25 September for catering purposes
- Enquiries: Catherine.Wong@monash.edu ph +61 3 9903 0640
No comments:
Post a Comment
Thankyou for your comment. We moderate all messages and may take a little time to review your comment. Please email inquiries to ccs.comms@monash.edu.